DIAGNOS Financial Statements From 2010 to 2025
| DGNOF Stock | USD 0.21 0.01 5.00% |
Check DIAGNOS financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among DIAGNOS's main balance sheet or income statement drivers, such as , as well as many indicators such as . DIAGNOS financial statements analysis is a perfect complement when working with DIAGNOS Valuation or Volatility modules.
DIAGNOS |
DIAGNOS OTC Stock Current Valuation Analysis
DIAGNOS's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current DIAGNOS Current Valuation | 12.4 M |
Most of DIAGNOS's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, DIAGNOS is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, DIAGNOS has a Current Valuation of 12.4 M. This is 99.91% lower than that of the Health Care Technology sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 99.93% higher than that of the company.
DIAGNOS Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining DIAGNOS's current stock value. Our valuation model uses many indicators to compare DIAGNOS value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across DIAGNOS competition to find correlations between indicators driving DIAGNOS's intrinsic value. More Info.DIAGNOS is rated # 3 in return on equity category among its peers. It also is rated # 3 in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the DIAGNOS's earnings, one of the primary drivers of an investment's value.About DIAGNOS Financial Statements
DIAGNOS stakeholders use historical fundamental indicators, such as DIAGNOS's revenue or net income, to determine how well the company is positioned to perform in the future. Although DIAGNOS investors may analyze each financial statement separately, they are all interrelated. For example, changes in DIAGNOS's assets and liabilities are reflected in the revenues and expenses on DIAGNOS's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in DIAGNOS. Please read more on our technical analysis and fundamental analysis pages.
DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company was founded in 1998 and is headquartered in Brossard, Canada. Diagnos operates under Health Information Services classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Other Information on Investing in DIAGNOS OTC Stock
DIAGNOS financial ratios help investors to determine whether DIAGNOS OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DIAGNOS with respect to the benefits of owning DIAGNOS security.